Latest news
REMS Programs for BCMA-Directed Therapies: Background, Best Practices, and Institutional Protocols - Pharmacy TimesPharmacy Times · Thu, 06 Aug 2026 12:42:09 GMTSuzetrigine Nears 1 Million Prescriptions as Reimbursed Access Expands for Nonopioid Acute Pain Treatment - Pharmacy TimesPharmacy Times · Tue, 04 Aug 2026 16:26:38 GMTBridging the Gap: Community-Based Administration and Access Barriers for BCMA-Targeted Therapies in Multiple Myeloma - Pharmacy TimesPharmacy Times · Thu, 30 Jul 2026 07:00:00 GMT